Cutera, Inc. (CUTR)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 72.1 Million USD | 13.32% |
| 2022 | 63.62 Million USD | 61.07% |
| 2021 | 39.5 Million USD | 38.57% |
| 2020 | 28.5 Million USD | -15.96% |
| 2019 | 33.92 Million USD | 21.09% |
| 2018 | 28.01 Million USD | -2.67% |
| 2017 | 28.78 Million USD | 92.17% |
| 2016 | 14.97 Million USD | 24.0% |
| 2015 | 12.07 Million USD | 9.92% |
| 2014 | 10.98 Million USD | 22.01% |
| 2013 | 9 Million USD | -18.97% |
| 2012 | 11.11 Million USD | 3.59% |
| 2011 | 10.72 Million USD | 66.42% |
| 2010 | 6.44 Million USD | 0.61% |
| 2009 | 6.4 Million USD | -35.45% |
| 2008 | 9.92 Million USD | 31.78% |
| 2007 | 7.53 Million USD | 44.31% |
| 2006 | 5.22 Million USD | -0.48% |
| 2005 | 5.24 Million USD | 74.6% |
| 2004 | 3 Million USD | 34.17% |
| 2003 | 2.23 Million USD | 63.91% |
| 2002 | 1.36 Million USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 80.2 Million USD | 11.24% |
| 2024 Q2 | 85.98 Million USD | 7.2% |
| 2023 Q4 | 72.1 Million USD | -0.79% |
| 2023 Q3 | 72.67 Million USD | 5.84% |
| 2023 Q2 | 68.66 Million USD | -4.39% |
| 2023 Q1 | 71.81 Million USD | 12.87% |
| 2023 FY | 72.1 Million USD | 13.32% |
| 2022 Q1 | 51.68 Million USD | 30.83% |
| 2022 Q2 | 45.41 Million USD | -12.13% |
| 2022 Q3 | 55.93 Million USD | 23.18% |
| 2022 Q4 | 63.62 Million USD | 13.75% |
| 2022 FY | 63.62 Million USD | 61.07% |
| 2021 Q3 | 35.49 Million USD | 2.61% |
| 2021 FY | 39.5 Million USD | 38.57% |
| 2021 Q4 | 39.5 Million USD | 11.3% |
| 2021 Q1 | 34.57 Million USD | 21.29% |
| 2021 Q2 | 34.59 Million USD | 0.04% |
| 2020 Q2 | 31.24 Million USD | -15.43% |
| 2020 Q4 | 28.5 Million USD | -2.81% |
| 2020 Q1 | 36.94 Million USD | 8.9% |
| 2020 FY | 28.5 Million USD | -15.96% |
| 2020 Q3 | 29.33 Million USD | -6.1% |
| 2019 Q4 | 33.92 Million USD | -0.36% |
| 2019 Q3 | 34.04 Million USD | 26.6% |
| 2019 Q2 | 26.88 Million USD | 0.86% |
| 2019 Q1 | 26.65 Million USD | -4.84% |
| 2019 FY | 33.92 Million USD | 21.09% |
| 2018 Q1 | 30.97 Million USD | 7.63% |
| 2018 Q3 | 31.32 Million USD | 3.93% |
| 2018 Q4 | 28.01 Million USD | -10.56% |
| 2018 FY | 28.01 Million USD | -2.67% |
| 2018 Q2 | 30.13 Million USD | -2.71% |
| 2017 Q2 | 16.91 Million USD | 7.92% |
| 2017 Q4 | 28.78 Million USD | 21.3% |
| 2017 FY | 28.78 Million USD | 92.17% |
| 2017 Q1 | 15.67 Million USD | 4.64% |
| 2017 Q3 | 23.72 Million USD | 40.29% |
| 2016 Q2 | 14.7 Million USD | 9.11% |
| 2016 FY | 14.97 Million USD | 24.0% |
| 2016 Q4 | 14.97 Million USD | -9.11% |
| 2016 Q3 | 16.47 Million USD | 12.08% |
| 2016 Q1 | 13.47 Million USD | 11.57% |
| 2015 FY | 12.07 Million USD | 9.92% |
| 2015 Q1 | 11.85 Million USD | 7.89% |
| 2015 Q2 | 13.52 Million USD | 14.05% |
| 2015 Q3 | 13.47 Million USD | -0.31% |
| 2015 Q4 | 12.07 Million USD | -10.39% |
| 2014 Q2 | 10.03 Million USD | 4.05% |
| 2014 FY | 10.98 Million USD | 22.01% |
| 2014 Q4 | 10.98 Million USD | -1.06% |
| 2014 Q3 | 11.1 Million USD | 10.73% |
| 2014 Q1 | 9.64 Million USD | 7.04% |
| 2013 FY | 9 Million USD | -18.97% |
| 2013 Q1 | 11.09 Million USD | -0.21% |
| 2013 Q3 | 10.42 Million USD | -0.92% |
| 2013 Q2 | 10.51 Million USD | -5.17% |
| 2013 Q4 | 9 Million USD | -13.58% |
| 2012 Q1 | 13.43 Million USD | 25.21% |
| 2012 Q3 | 12.47 Million USD | -1.93% |
| 2012 FY | 11.11 Million USD | 3.59% |
| 2012 Q2 | 12.72 Million USD | -5.3% |
| 2012 Q4 | 11.11 Million USD | -10.92% |
| 2011 Q3 | 9.65 Million USD | 16.36% |
| 2011 Q4 | 10.72 Million USD | 11.08% |
| 2011 FY | 10.72 Million USD | 66.42% |
| 2011 Q1 | 7.26 Million USD | 12.73% |
| 2011 Q2 | 8.3 Million USD | 14.21% |
| 2010 FY | 6.44 Million USD | 0.61% |
| 2010 Q3 | 7.14 Million USD | 2.72% |
| 2010 Q4 | 6.44 Million USD | -9.76% |
| 2010 Q2 | 6.95 Million USD | 0.03% |
| 2010 Q1 | 6.95 Million USD | 8.5% |
| 2009 Q3 | 7.88 Million USD | -9.4% |
| 2009 Q4 | 6.4 Million USD | -18.72% |
| 2009 Q1 | 9.84 Million USD | -0.82% |
| 2009 Q2 | 8.7 Million USD | -11.62% |
| 2009 FY | 6.4 Million USD | -35.45% |
| 2008 FY | 9.92 Million USD | 31.78% |
| 2008 Q3 | 8.75 Million USD | 1.67% |
| 2008 Q4 | 9.92 Million USD | 13.41% |
| 2008 Q2 | 8.6 Million USD | -8.26% |
| 2008 Q1 | 9.38 Million USD | 24.57% |
| 2007 Q3 | 6.52 Million USD | -2.87% |
| 2007 Q4 | 7.53 Million USD | 15.47% |
| 2007 Q2 | 6.71 Million USD | 3.1% |
| 2007 Q1 | 6.51 Million USD | 24.81% |
| 2007 FY | 7.53 Million USD | 44.31% |
| 2006 FY | 5.22 Million USD | -0.48% |
| 2006 Q2 | 6.44 Million USD | -3.52% |
| 2006 Q4 | 5.22 Million USD | -6.08% |
| 2006 Q1 | 6.68 Million USD | 27.44% |
| 2006 Q3 | 5.55 Million USD | -13.82% |
| 2005 Q2 | 4 Million USD | 7.03% |
| 2005 Q4 | 5.24 Million USD | 4.9% |
| 2005 FY | 5.24 Million USD | 74.6% |
| 2005 Q1 | 3.74 Million USD | 24.6% |
| 2005 Q3 | 5 Million USD | 24.81% |
| 2004 Q2 | 2.93 Million USD | 5.35% |
| 2004 Q1 | 2.78 Million USD | 24.43% |
| 2004 Q3 | 3.1 Million USD | 5.93% |
| 2004 Q4 | 3 Million USD | -3.38% |
| 2004 FY | 3 Million USD | 34.17% |
| 2003 Q4 | 2.23 Million USD | 0.0% |
| 2003 FY | 2.23 Million USD | 63.91% |
| 2002 FY | 1.36 Million USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -2078.278% |
| BrainsWay Ltd. | 3.71 Million USD | -1839.763% |
| Cerus Corporation | 39.86 Million USD | -80.849% |
| Envoy Medical, Inc. | 1.4 Million USD | -5035.399% |
| electroCore, Inc. | 2.16 Million USD | -3238.009% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -15677.024% |
| IceCure Medical Ltd | 2.27 Million USD | -3069.275% |
| Inogen, Inc. | 21.84 Million USD | -230.133% |
| OrthoPediatrics Corp. | 105.85 Million USD | 31.884% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -25835.612% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -7210099900.0% |
| MaxCyte, Inc. | 12.22 Million USD | -489.59% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -4075.687% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -45994.489% |
| Orthofix Medical Inc. | 222.16 Million USD | 67.546% |
| PAVmed Inc | 1.01 Million USD | -6989.584% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | -261.209% |
| RxSight, Inc. | 17.42 Million USD | -313.874% |
| Sight Sciences, Inc. | 7.84 Million USD | -818.601% |
| SI-BONE, Inc. | 20.24 Million USD | -256.072% |
| TELA Bio, Inc. | 13.16 Million USD | -447.797% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | -146.541% |
| Vivos Therapeutics, Inc. | 1.00 USD | -7210099900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | -1585.39% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -31248.261% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -2960.314% |
| CVRx, Inc. | 10.98 Million USD | -556.478% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -18383.834% |
| Bioventus Inc. | 91.33 Million USD | 21.057% |
| Venus Concept Inc. | 28.67 Million USD | -151.433% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -2733.045% |
| LivaNova PLC | 147.88 Million USD | 51.246% |
| 908 Devices Inc. | 14.93 Million USD | -382.668% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 47.311% |
| Nemaura Medical Inc. | 1.75 Million USD | -4008.666% |
| NeuroPace, Inc. | 11.21 Million USD | -542.955% |
| LENSAR, Inc. | 15.68 Million USD | -359.564% |
| Apyx Medical Corporation | 9.92 Million USD | -626.605% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -2597.381% |
| BioSig Technologies, Inc. | -103 Thousand USD | 70100.971% |
| Anika Therapeutics, Inc. | 46.38 Million USD | -55.437% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | -811.402% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 81.494% |
| Axonics, Inc. | 79.94 Million USD | 9.806% |
| Outset Medical, Inc. | 49.21 Million USD | -46.502% |
| IRIDEX Corporation | 9.9 Million USD | -627.852% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | -81.359% |
| IRadimed Corporation | 12.82 Million USD | -462.358% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -9437.169% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -27158.636% |
| Telesis Bio, Inc. | 4.02 Million USD | -1691.329% |
| Viemed Healthcare, Inc. | 4.6 Million USD | -1465.942% |
| Varex Imaging Corporation | 277.5 Million USD | 74.018% |
| Quipt Home Medical Corp. | 18.32 Million USD | -293.441% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | -330.634% |
| Dynatronics Corporation | 5.59 Million USD | -1188.905% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | -1827.319% |
| Semler Scientific, Inc. | 445 Thousand USD | -16102.472% |
| InMode Ltd. | 45.09 Million USD | -59.887% |
| Bruker Corporation | 968.3 Million USD | 92.554% |
| Cytosorbents Corporation | 3.68 Million USD | -1859.198% |
| DexCom, Inc. | 559.6 Million USD | 87.116% |
| Align Technology, Inc. | 296.9 Million USD | 75.716% |
| Viveve Medical, Inc. | 1.47 Million USD | -4798.166% |
| ZimVie Inc. | 79.6 Million USD | 9.421% |
| Movano Inc. | 1.51 Million USD | -4665.433% |
| Cytek Biosciences, Inc. | 60.87 Million USD | -18.437% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -45994.489% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 54.348% |
| Profound Medical Corp. | 6.95 Million USD | -936.941% |
| Insulet Corporation | 402.6 Million USD | 82.091% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | -385.889% |
| iCAD, Inc. | 917 Thousand USD | -7762.704% |
| Nuwellis, Inc. | 1.99 Million USD | -3510.466% |
| Biotricity, Inc. | 1.87 Million USD | -3736.38% |
| iRhythm Technologies, Inc. | 13.97 Million USD | -416.002% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -3323.599% |
| PAVmed Inc. | 1.01 Million USD | -6989.584% |
| BIOLASE, Inc. | 11.43 Million USD | -530.639% |
| Beyond Air, Inc. | 2.12 Million USD | -3289.798% |
| FONAR Corporation | 2.71 Million USD | -2555.222% |
| AxoGen, Inc. | 23.02 Million USD | -213.21% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | -220.065% |
| Inari Medical, Inc. | 42.9 Million USD | -68.068% |
| UFP Technologies, Inc. | 70.19 Million USD | -2.721% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -11359.537% |
| Tenon Medical, Inc. | 554 Thousand USD | -12914.621% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -4231.106% |
| AdaptHealth Corp. | 113.64 Million USD | 36.554% |
| Sintx Technologies, Inc. | 888 Thousand USD | -8019.482% |
| NanoVibronix, Inc. | 2.73 Million USD | -2539.129% |
| Quanterix Corporation | 22.36 Million USD | -222.383% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | -385.627% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | -27.216% |
| TransMedics Group, Inc. | 44.23 Million USD | -62.995% |
| ReWalk Robotics Ltd. | 5.65 Million USD | -1175.447% |
| NeuroMetrix, Inc. | 1.55 Million USD | -4523.554% |
| Hyperfine, Inc. | 6.58 Million USD | -995.427% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 9.805% |
| Biomerica, Inc. | 2.37 Million USD | -2934.554% |
| Bone Biologics Corporation | -328.84 Thousand USD | 22025.594% |
| AVITA Medical, Inc. | 3.12 Million USD | -2209.884% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | -141.334% |